ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Assessment Of Severity Of Covid-19 Vs D-Nlr And Rdw, Plr: A Retrospective Study Of Our Centre


    Dr Neeti Agarwal, Dr. Shilpa Agarwal, Dr Chandan Sahu, Dr P.D. Agarwal
    JCDR. 2023: 1368-1378

    Abstract

    We know turnaround time for the complete blood count is much faster than that of various inflammatory markers like LDH, CRP, interleukins like IL-6, D-dimer. Thus using cell counts as a marker of severity and the prognosis is need of the hour. This will reduce the burden of the health care facilities. Complete blood count including the variation in RBC, WBC and platelets changes has been thoroughly studied. Various retrospective studies have shown that the absolute lymphocyte count can be taken as a marker of severity in COVID 19 patients. In December 2019, several cases of new corona virus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARSCoV-2) have been emerged from Wuhan, China, which was later declared as a global pandemic by World Health Organisation (WHO) on March 11th 2020.

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 7

    Keywords